Assura Plc (LON:AGR – Get Free Report) insider Jonathan Murphy bought 774 shares of Assura stock in a transaction that occurred on Tuesday, May 7th. The stock was bought at an average price of GBX 42 ($0.53) per share, with a total value of £325.08 ($408.39).
Jonathan Murphy also recently made the following trade(s):
- On Friday, April 5th, Jonathan Murphy acquired 786 shares of Assura stock. The stock was bought at an average price of GBX 41 ($0.52) per share, for a total transaction of £322.26 ($404.85).
- On Tuesday, March 5th, Jonathan Murphy bought 351 shares of Assura stock. The shares were purchased at an average cost of GBX 43 ($0.54) per share, for a total transaction of £150.93 ($189.61).
Assura Stock Down 0.2 %
Shares of LON:AGR opened at GBX 42.60 ($0.54) on Thursday. The company’s fifty day moving average is GBX 41.57 and its 200-day moving average is GBX 43.47. The company has a debt-to-equity ratio of 82.21, a quick ratio of 2.84 and a current ratio of 1.29. Assura Plc has a 52 week low of GBX 38.38 ($0.48) and a 52 week high of GBX 53 ($0.67). The company has a market capitalization of £1.27 billion, a PE ratio of -710.00, a P/E/G ratio of 3.60 and a beta of 0.30.
Assura Dividend Announcement
Analysts Set New Price Targets
A number of research firms have weighed in on AGR. Barclays reiterated an “overweight” rating and set a GBX 53 ($0.67) price target on shares of Assura in a research note on Friday, February 9th. Peel Hunt downgraded shares of Assura to an “add” rating and set a GBX 48 ($0.60) price target on the stock. in a research note on Wednesday, March 20th. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of GBX 52 ($0.65).
About Assura
Assura plc is a national healthcare premises specialist and UK REIT based in Altrincham, UK – caring for more than 600 primary healthcare buildings, from which over six million patients are served. A constituent of the FTSE 250 and the EPRA indices, as at 30 September 2023, Assura's portfolio was valued at £2.7 billion.
Featured Stories
- Five stocks we like better than Assura
- Why Invest in 5G? How to Invest in 5G Stocks
- Lucid’s Stock Price is Still in Reverse: New Lows Are Coming
- What is a Secondary Public Offering? What Investors Need to Know
- Generac Powers Ahead on the Electrification Mega-Trend
- What is a buyback in stocks? A comprehensive guide for investors
- PulteGroup Wins and Wins More on Interest Rate Cuts
Receive News & Ratings for Assura Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura and related companies with MarketBeat.com's FREE daily email newsletter.